Leukotriene antagonists and inhibitors as modulators of IgE-mediated reactions.
Ford-Hutchinson
A W
AW
Merck Frosst Centre for Therapeutic Research, Point Claire-Dorval, Quebec, Canada.
D001094:Arachidonate 5-Lipoxygenase / Q000502:physiology; D001249:Asthma / Q000276:immunology*; D002986:Clinical Trials as Topic; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D007211:Indoles; D048448:Phenylcarbamates; D011422:Propionates / Q000276:immunology; D011804:Quinolines / Q000276:immunology; D011971:Receptors, Immunologic / Q000037:antagonists & inhibitors*; D013189:SRS-A / Q000037:antagonists & inhibitors / Q000276:immunology*; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000276:immunology
D007211:Indoles; D048448:Phenylcarbamates; D011422:Propionates; D011804:Quinolines; D011971:Receptors, Immunologic; D013189:SRS-A; D013449:Sulfonamides; D014105:Tosyl Compounds; D007073:Immunoglobulin E; C059141:verlukast; D001094:Arachidonate 5-Lipoxygenase; C062735:zafirlukast